HPV-Related Oropharyngeal Cancer: The Importance of Early Detection & Prevention
AHNS Educational Series: Presented by the AHNS Cancer Prevention and Survivorship/Supportive Care/Rehabilitation Services In Partnership with the Head and Neck Cancer Alliance
Wednesday July, 20, 2022 at 7:00 PM EST
This session is an hour and complimentary for all!
The AHNS gratefully acknowledges the generous educational grant in support of this activity from Roche.
Ann Gillenwater, MD– AHNS Cancer Prevention Service Vice-Chair
Laura Dooley, MD – AHNS Cancer Prevention Service Member
Warren Swegal, MD – AHNS Survivorship/Supportive Care/Rehabilitation Service Member
Kristin Oliver, MD– Pediatrician
Michael Murphy –Survivor, Head and Neck Cancer Alliance Ambassador
At the end of this one-hour webinar, participants will be able to:
1. Identify the current trends in the epidemiology of HPV-related oropharyngeal cancer
2. Recognize the common clinical presentation of HPV-related oropharyngeal cancer
3. Distinguish the short and long-term side effects that come with head and neck cancer treatment
4. Articulate current barriers to population-based screening for HPV-related oropharyngeal cancer, thus emphasizing the importance of primary prevention
5. Outline the current indications for HPV-vaccination and the role it plays in prevention of HPV-related cancers.